CBO Agrees To Seek New Data On How IRA Affects Drug Innovation

By Gabrielle Wanneh / December 21, 2023 at 5:39 PM

The Congressional Budget Office (CBO) is heeding calls from House Budget Committee Republicans to gather new data on how the Inflation Reduction Act’s price control policies are affecting pharmaceutical innovation.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.